Dupilumab Demonstrates Histologic, Endoscopic Improvement in Pediatric Patients with EoE; Results showed higher-exposure dupilumab met the study's primary endpoint for peak esophageal intraepithelial count ≤6 eos/high-power field.

Press/Media

Period26 Oct 2023

Media coverage

2

Media coverage

  • TitleDupilumab Demonstrates Histologic, Endoscopic Improvement in Pediatric Patients with EoE; Results showed higher-exposure dupilumab met the study's primary endpoint for peak esophageal intraepithelial count ≤6 eos/high-power field.
    Media name/outletConsultant Live
    Country/TerritoryUnited States
    Date26/10/23
    PersonsMirna Chehade
  • TitleDupilumab Demonstrates Histologic, Endoscopic Improvement in Pediatric Patients with EoE
    Media name/outletHCP Live
    Country/TerritoryUnited States
    Date26/10/23
    PersonsMirna Chehade